Seth Heldenbrand
Title | Associate Dean for Experiential Educ |
---|
Institution | University of Arkansas for Medical Sciences |
---|
Department | Experiential Education, College of Pharmacy |
---|
Address | 6/110C ED II 320 UAMS Campus Dr. Mail Slot # 522 Little Rock AR 72205
|
---|
Phone | 501-686-6392 |
---|
vCard | Download vCard |
---|
|
|
|
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
Don't see publications published under other names? Login to add alternative names.
-
MacCamy KL, Heldenbrand SD, Robinson JD. A multisite, longitudinal study assessing prevalence of depression in student pharmacists. Am J Pharm Educ. 2024 Feb; 88(2):100634. PMID: 38141954.
-
Kanmaz TJ, Culhane NS, Berenbrok LA, Jarrett J, Johanson EL, Ruehter VL, Trolli E, Welch LH, Heldenbrand SD. A Curriculum Crosswalk of the Core Entrustable Professional Activities for New Pharmacy Graduates. Am J Pharm Educ. 2020 11; 84(11):8077. PMID: 34283755.
-
Fuller KA, Heldenbrand SD, Smith MD, Malcom DR. A Paradigm Shift in US Experiential Pharmacy Education Accelerated by the COVID-19 Pandemic. Am J Pharm Educ. 2020 06; 84(6):ajpe8149. PMID: 32665722.
-
Heldenbrand SD, Dayer LE, Martin BC, O'Brien C, Choi AN, Gubbins PO, Hawthorne J, Ramey M, Willis K, Flowers SK. APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA. Am J Pharm Educ. 2018 09; 82(7):6326. PMID: 30323388.
-
Maldonado AQ, West-Thielke P, Dew MA, Peipert JD, Heldenbrand S, Kaiser TE, Chisholm-Burns M, Potter LM. Meeting report: Consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation. Clin Transplant. 2018 09; 32(9):e13362. PMID: 30053319.
-
Pinelli NR, Sease JM, Nola K, Kyle JA, Heldenbrand SD, Penzak SR, Ginsburg DB. The Importance of Authentic Leadership to all Generations Represented within Academic Pharmacy. Am J Pharm Educ. 2018 08; 82(6):6694. PMID: 30181676.
-
Choi AN, Flowers SK, Heldenbrand SD. Becoming more holistic: A literature review of nonacademic factors in the admissions process of colleges and schools of pharmacy and other health professions. Curr Pharm Teach Learn. 2018 10; 10(10):1429-1437. PMID: 30527373.
-
Dayer LE, Shilling R, Van Valkenburg M, Martin BC, Gubbins PO, Hadden K, Heldenbrand S. Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points. JMIR Mhealth Uhealth. 2017 Apr 19; 5(4):e45. PMID: 28428169.
-
Heldenbrand S, Li C, Cross RP, DePiero KA, Dick TB, Ferguson K, Kim M, Newkirk E, Park JM, Sudaria-Kerr J, Tichy EM, Ueda KR, Weng R, Wisniewski J, Gabardi S. Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients. Transpl Infect Dis. 2016 Dec; 18(6):904-912. PMID: 27639246.
-
Doyle IC, Maldonado AQ, Heldenbrand S, Tichy EM, Trofe-Clark J. Nonadherence to therapy after adult solid organ transplantation: A focus on risks and mitigation strategies. Am J Health Syst Pharm. 2016 Jun 15; 73(12):909-20. PMID: 27189855.
-
Heldenbrand S, Martin BC, Gubbins PO, Hadden K, Renna C, Shilling R, Dayer L. Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients. J Am Pharm Assoc (2003). 2016 May-Jun; 56(3):293-302. PMID: 27067551.
-
Heldenbrand SD, Flowers SK, Bordelon BJ, Gubbins PO, O'Brien C, Stowe CD, Martin BC. Multiple Mini-Interview Performance Predicts Academic Difficulty in the PharmD Curriculum. Am J Pharm Educ. 2016 Mar 25; 80(2):27. PMID: 27073280.
-
Syal G, Heldenbrand SD, Duarte-Rojo A. Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir. Am J Ther. 2016 Mar-Apr; 23(2):e570-1. PMID: 25549078.
-
Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst. J Am Pharm Assoc (2003). 2013 Jul-Aug; 53(4):345. PMID: 23892801.
-
Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003). 2013 Mar-Apr; 53(2):172-81. PMID: 23571625.
-
Gubbins PO, Heldenbrand S. Clinically relevant drug interactions of current antifungal agents. Mycoses. 2010 Mar 01; 53(2):95-113. PMID: 20002883.
-
Warmack TS, Estes MA, Heldenbrand S, Franks AM. Beta-adrenergic antagonists in hypertension: a review of the evidence. Ann Pharmacother. 2009 Dec; 43(12):2031-43. PMID: 19934392.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2009 | 2 | 2013 | 2 | 2016 | 5 | 2017 | 1 | 2018 | 4 | 2020 | 2 | 2023 | 1 |
To return to the timeline, click here.
|
Heldenbrand's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|